CHICAGO: A landmark research project by Newcastle University experts could dramatically improve the success rate of clinical trials for Alzheimer’s treatment.
The multimillion pound Deep and Frequent Phenotyping study will see the most thorough tests to detect the disease performed on volunteers.
Funded by the National Institute of Health Research (NIHR) and the Medical Research Council (MRC), the £6.9m research project has been designed to identify measurable characteristics, known as biomarkers, which can detect the occurrence of Alzheimer’s disease very early on – when a person may have no obvious symptoms.
Lynn Rochester, professor of human movement science at Newcastle University, is leading the part of the project which focuses on people’s movement and gait – the way someone walks.